Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy
Diabetic Medicine · 2024
DOI: 10.1111/dme.15262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Christopher W Rowe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, New South Wales, Australia. Hauptthemen laut MEDLINE: Diabetes, Gestational, Diabetes Mellitus, Type 2, Hyperglycemia, Pre-Eclampsia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Bespoke glycaemic control strategies following antenatal corticosteroids for women with diabetes in pregnancy (DIP) may mitigate hyperglycaemia. This study aims to identify predictive factors for the glycaemic response to betamethasone in a large cohort of women with DIP.
Methods
Evaluation of a prospective cohort study of 347 consecutive DIP pregnancies receiving two doses of 11.4 mg betamethasone 24 h apart between 2017 and 2021 and treated with the Pregnancy‐IVI intravenous insulin protocol. Regression modelling identified factors associated with maternal glycaemic time‐in‐range (TIR) and maternal insulin requirements following betamethasone. Factors associated with neonatal hypoglycaemia (glucose
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, New South Wales, Australia.
- School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
- Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
ORCID-Profile: Christopher W Rowe
Zitieren
APA
Rowe, C. W., Rosee, P., Sathiakumar, A., Ramesh, S., Qiao, V., Huynh, J., Dennien, G., Weaver, N., & Wynne, K. (2024). Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy. Diabetic Medicine. https://doi.org/10.1111/dme.15262
Vancouver
Rowe CW, Rosee P, Sathiakumar A, Ramesh S, Qiao V, Huynh J, et al. Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy. Diabetic Medicine. 2024. doi:10.1111/dme.15262
BibTeX
@article{Rowe2024,
author = {Rowe, Christopher W and Rosee, Patrick and Sathiakumar, Angeline and Ramesh, Soundarya and Qiao, Vivian and Huynh, Jason and Dennien, Georgia and Weaver, Natasha and Wynne, Katie},
title = {Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy},
journal = {Diabetic Medicine},
year = {2024},
doi = {10.1111/dme.15262}
}
EUVIMED